Moneycontrol PRO
you are here: HomeNewsTrendsHealth

Cases of AY.4.2 variant of coronavirus reach 7 in Karnataka

Maintaining that the COVID-19 cases are under control in the state, Randeep said the government is making a negative RT-PCR test report, obtained 72 hours before arrival, mandatory for those coming from abroad to the state.

October 27, 2021 / 12:17 PM IST
Image: Shutterstock

Image: Shutterstock

The number of Delta AY.4.2 variant of coronavirus, which is spreading rapidly in some foreign countries, has increased to seven in Karnataka with three more people found to be infected with it in the city.

Speaking to reporters, State Health and Family Welfare Commissioner D Randeep said, "There are seven cases (of AY.4.2) in the state — three in Bengaluru and four in different parts of the state.”

Maintaining that the COVID-19 cases are under control in the state, Randeep said the government is making a negative RT-PCR test report, obtained 72 hours before arrival, mandatory for those coming from abroad to the state.

"The test report has to be uploaded on a portal called Air Suvidha. Other than that, there is no restrictions like quarantining people,” Randeep clarified.

He further said the Centre and the state will initiate certains measures to check the super-spreader variant of COVID-19, which has spread in some foreign countries.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
There are no reports of deaths due to the new variant but one or two people have been hospitalised, he added.
PTI
first published: Oct 27, 2021 12:17 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark